On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading
On May 15, 2024, Health Policy Watch published the latest draft (as of May 10, 2024) of the WHO Pandemic Accord by the Intergovernmental Negotiating Body (INB). In order to provide a better understanding of what is and is not… Continue Reading
This was sent via email today. Jamie ————— May 1, 2024 Anne Yu Director for Global Pandemic Preparedness Development, Global Health and Humanitarian Response, National Security Council Staff, Executive Office of the President Dear Anne Yu, I’m guessing you are… Continue Reading
PDF version is available here: KEI.MutuallyAgreedTerms.A_INB_9_3Rev1.22April2024draft KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024 James Love Knowledge Ecology International April 28, 2024, revised April 29, 2024 Introduction… Continue Reading
To get an idea of the challenges of getting agreement on the WHO pandemic accord text, consider the state of just one article on Saturday, March 23, 2024. Article 11 has 6 paragraphs on technology transfer. According to an analysis… Continue Reading
On January 29, 2024, KEI submitted comments in response the Federal Register notice posted by the Department of Health and Human Services (HHS) concerning, “the Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments Being Considered Under… Continue Reading
KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading
WHO-zero-draft-pandemic-treaty-1Feb2023 There is much to like in this draft on topics such as intellectual property rights, transparency, benefit sharing and equity. Easy to see why big drug companies have been alarmed at the direction of the WHO work on this.… Continue Reading
This is what delegates will be discussing at the next INB meeting the week of December 5, 2022, in Geneva. ADVANCE_for_16_November_A_INB3_3_E From the document: “In preparing a conceptual zero draft, the Bureau started by integrating the above-mentioned input into the… Continue Reading
